Useless drugs are not placebos: lessons from flunarizine and cinnarizine

Discontinuation of pharmacological treatment of children and adolescents with attention deficit hyperactivity disorder: meta-analysis of 63 studies enrolling 11,788 patients.

Psychopharmacology·2017

Efficacy, safety and variability in pharmacotherapy for adults with attention deficit hyperactivity disorder: a meta-analysis and meta-regression in over 9000 patients.

Psychopharmacology·2015

Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence.

Journal of psychopharmacology (Oxford, England)·2014

Workplace bullying and psychotropic drug use: the mediating role of physical and mental health status.

The Annals of occupational hygiene·2010

Workplace bullying and sleep disturbances: findings from a large scale cross-sectional survey in the French working population.

Sleep·2009

Analgesics for pain after traumatic or orthopaedic surgery: what is the evidence--a systematic review.

European journal of clinical pharmacology·2006

The public health challenges of children's and adolescents' digital media use: applying the digital determinants of health as an interpretive framework.

Lancet (London, England)·2026

Governing the digital determinants of health for children and young people: a global public health imperative.

Lancet (London, England)·2026

The digital determinants of health: a new era for global public health.

Lancet (London, England)·2026

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Successful use of a Janus-kinase (JAK) inhibitor in chronic chikungunya arthritis refractory to conventional synthetic DMARDs: a case report.

Modern rheumatology case reports·2026

Simvastatin Mitigates Chemotherapy-Induced Depressive-Like Behaviors in Rats.

Archiv der Pharmazie·2026

The endophyte secondary metabolite phenazine-1-carboxylic acid promotes tanshinone biosynthesis in Salvia miltiorrhiza callus.

Journal of natural medicines·2026

The 'less side effect, more benefit' hypothesis: explaining the colchicine paradox.

Current medical research and opinion·2026

Investigating the neurological function and anti-inflammatory effects of resveratrol in small mammal spinal cord injury models: A systematic review and meta-analysis.

Surgical neurology international·2026

Psychedelics and disorders of consciousness: a new frontier in neurotherapeutics.

Molecular psychiatry·2026

Related Experiment Videos

Useless drugs are not placebos: lessons from flunarizine and cinnarizine

Related Concept Videos

Discontinuation of pharmacological treatment of children and adolescents with attention deficit hyperactivity disorder: meta-analysis of 63 studies enrolling 11,788 patients.

Efficacy, safety and variability in pharmacotherapy for adults with attention deficit hyperactivity disorder: a meta-analysis and meta-regression in over 9000 patients.

Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence.

Workplace bullying and psychotropic drug use: the mediating role of physical and mental health status.

Workplace bullying and sleep disturbances: findings from a large scale cross-sectional survey in the French working population.

Analgesics for pain after traumatic or orthopaedic surgery: what is the evidence--a systematic review.

The public health challenges of children's and adolescents' digital media use: applying the digital determinants of health as an interpretive framework.

Governing the digital determinants of health for children and young people: a global public health imperative.

The digital determinants of health: a new era for global public health.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Successful use of a Janus-kinase (JAK) inhibitor in chronic chikungunya arthritis refractory to conventional synthetic DMARDs: a case report.

Simvastatin Mitigates Chemotherapy-Induced Depressive-Like Behaviors in Rats.

The endophyte secondary metabolite phenazine-1-carboxylic acid promotes tanshinone biosynthesis in Salvia miltiorrhiza callus.

The 'less side effect, more benefit' hypothesis: explaining the colchicine paradox.

Investigating the neurological function and anti-inflammatory effects of resveratrol in small mammal spinal cord injury models: A systematic review and meta-analysis.

Psychedelics and disorders of consciousness: a new frontier in neurotherapeutics.

Related Experiment Videos

Useless drugs are not placebos: lessons from flunarizine and cinnarizine

Related Concept Videos

Related Articles